Cotinga Pharmaceuticals Beta
Qual é o Beta de Cotinga Pharmaceuticals?
O Beta de Cotinga Pharmaceuticals, Inc. é 1.62
Qual é a definição de Beta?
BETA indica se uma ação é mais ou menos volátil do que o mercado como um todo. Um beta menor que 1 indica que o estoque é menos volátil do que o mercado, enquanto um beta maior que 1 indica que o estoque é mais volátil. A volatilidade é medida como a flutuação do preço em torno da média.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta de empresas na Setor Health Care em TSXV em comparação com Cotinga Pharmaceuticals
O que Cotinga Pharmaceuticals faz?
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.
Empresas com beta semelhantes a Cotinga Pharmaceuticals
- Royal Mail Plc tem Beta de 1.62
- Largo Resources tem Beta de 1.62
- Conifex Timber tem Beta de 1.62
- Nath Bio-Genes (India) tem Beta de 1.62
- Azimut Exploration tem Beta de 1.62
- Infineon Technologies AG tem Beta de 1.62
- Cotinga Pharmaceuticals tem Beta de 1.62
- Empired tem Beta de 1.62
- Neogenomics tem Beta de 1.62
- DBV Technologies SA tem Beta de 1.62
- Falco Resources tem Beta de 1.62
- Turquoise Hill Resources tem Beta de 1.62
- Envirosuite tem Beta de 1.62